Clinical trials
Phase 1/2 Pancreatic Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
218 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2004 | 6 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 9 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 9 |
| 2017 | 16 |
| 2018 | 14 |
| 2019 | 16 |
| 2020 | 11 |
| 2021 | 12 |
| 2022 | 14 |
| 2023 | 13 |
| 2024 | 9 |
| 2025 | 14 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 90 |
| Terminated | 43 |
| Recruiting | 42 |
| Active, not recruiting | 20 |
| Withdrawn | 9 |
| Unknown status | 8 |
| Suspended | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 14 |
| Eli Lilly and Company | 5 |
| M.D. Anderson Cancer Center | 5 |
| Gilead Sciences | 4 |
| ImmunityBio, Inc. | 4 |
| Revolution Medicines, Inc. | 4 |
| Bristol-Myers Squibb | 3 |
| NewLink Genetics Corporation | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| University of Virginia | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 218 |
| Colorectal Neoplasms | 49 |
| Carcinoma, Non-Small-Cell Lung | 43 |
| Ovarian Neoplasms | 37 |
| Colonic Neoplasms | 35 |
| Neoplasms | 34 |
| Breast Neoplasms | 32 |
| Stomach Neoplasms | 30 |
| Neoplasm Metastasis | 27 |
| Lung Neoplasms | 22 |
Trials
Showing 1 to 25 of 218. Each trial links to its page on Pharma Observatory.
118 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.